← Eichor
Study identifier: NCT06563206 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Exergame and Robotic Therapy Impact on Tenascin-C and Functional Outcome on Stroke Patients

Condition: Stroke · Paralysis Arm  ·  Sponsor: Hasanuddin University

PhaseNA
Planned participants48
Who can joinAll sexes, N/A to no upper limit
Healthy volunteersNo

About this study

This clinical trial aims to compare the effectiveness of Robotic versus Exergame versus Standard therapy to improve hand function among post-stroke patients. The main questions it aims to answer are: 1, Effectiveness of interventions in functional outcome recovery across time 2. Effectiveness of interventions in affecting Tenascin-C level 3. Clinical outcome difference between all interventions Participants will be allocated into three groups, either a robotic group, exergame group as the main interventions, and standard rehabilitation group as the active comparator. A serial follow-up will be conducted to assess the selected clinical outcome and differences in outcome

This description comes directly from the study's public registry record.

Talk to the study team

Auliyah Fadly, MD  ·  +6281234328649  ·  muh.auliyah.fadly@gmail.com

Always discuss trial participation with your own doctor first.

Locations (2)

Hasanuddin University, Faculty of MedicineMakassar, South Sulawesi, IndonesiaRecruiting
Wahidin Sudirohusodo General HospitalMakassar, South Sulawesi, IndonesiaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06563206